Abstract
The One Health (OH) approach describes the interconnection between the health of animals, humans, and the environment. The need for collaboration between the veterinary and human fields is increasing due to the rise in several infectious diseases that cross human–animal barriers and need to be addressed jointly. However, such collaboration is not evident in practice, especially for non-zoonotic diseases. A qualitative research approach was used to explore the barriers and enablers influencing collaborative efforts on the development of vaccines for the non-zoonotic RSV virus. It was found that in the European context, most veterinary and human health professionals involved in RSV vaccine development see themselves as belonging to two distinct groups, indicating a lack of a common goal for collaboration. Next to this, the different conceptualizations of the OH approach, and the fact that RSV is not a zoonotic disease, strengthens the opinion that there is no shared need for collaboration. This paper adds insights on how, for a non-zoonotic situation, collaboration between human and veterinary professionals shaped the development of vaccines in both areas; thus, improving public health requires awareness, mutual appreciation, and shared goal setting.
| Original language | English |
|---|---|
| Article number | 1137 |
| Pages (from-to) | 1-14 |
| Number of pages | 14 |
| Journal | Vaccines |
| Volume | 11 |
| Issue number | 7 |
| Early online date | 23 Jun 2023 |
| DOIs | |
| Publication status | Published - Jul 2023 |
Bibliographical note
Funding Information:Government funding is limited, which is a factor potentially increasing competition rather than cooperation among the human and veterinary fields [], so it is pivotal to raise the urgency and political focus around RSV, for example, by stressing the burden of HRSV and BRSV on global health and farming, as well as the advantages of prevention. European initiatives and grants have already been used to foster collaborations among different institutes to develop vaccines. For example, the SAPHIR (European Commission, 2020) project financed by Horizon 2020, focused on BRSV vaccine research, among other animal conditions. Other examples where opportunities led to the reforming of the political agenda, were the Salmonella and Campylobacter disease outbreaks in Sweden, leading to the development and implementation of new legislation [].
Funding Information:
The contribution of L.v.d.B. to this study was financially supported by her personal grant by the Veni SGW program (project number VI. Veni 201S.044) of the Dutch Research Council (NWO).
Publisher Copyright:
© 2023 by the authors.
Funding
Government funding is limited, which is a factor potentially increasing competition rather than cooperation among the human and veterinary fields [], so it is pivotal to raise the urgency and political focus around RSV, for example, by stressing the burden of HRSV and BRSV on global health and farming, as well as the advantages of prevention. European initiatives and grants have already been used to foster collaborations among different institutes to develop vaccines. For example, the SAPHIR (European Commission, 2020) project financed by Horizon 2020, focused on BRSV vaccine research, among other animal conditions. Other examples where opportunities led to the reforming of the political agenda, were the Salmonella and Campylobacter disease outbreaks in Sweden, leading to the development and implementation of new legislation []. The contribution of L.v.d.B. to this study was financially supported by her personal grant by the Veni SGW program (project number VI. Veni 201S.044) of the Dutch Research Council (NWO).
Keywords
- collaboration
- HRSV and BRSV
- human and veterinary health
- knowledge sharing
- KOLs
- vaccine development